{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:12:56Z","timestamp":1792883576861,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"am","delay-in-days":250,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.mycmed.2022.101276","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:36:05Z","timestamp":1648557365000},"page":"101276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antifungal combination therapy for invasive fungal infections in a paediatric oncology and haematology department: A retrospective analysis of practice"],"prefix":"10.1016","volume":"32","author":[{"given":"Gabriel","family":"Lignieres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Guitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Alby-Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Rambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-8454","authenticated-orcid":false,"given":"Marie-Dominique","family":"Tabone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2022.101276_bib0001","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2021.05.016","article-title":"Invasive fungal infections in immunocompromised children: novel insight following a national study","volume":"236","author":"Olivier-Gougenheim","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.mycmed.2022.101276_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ejh.12910","article-title":"Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients","volume":"99","author":"Cesaro","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.mycmed.2022.101276_bib0003","first-page":"37","article-title":"Invasive fungal infections in a pediatric hematology-oncology department: A 16-year retrospective study","volume":"6","author":"Kazakou","year":"2020","journal-title":"Curr Med Mycol"},{"key":"10.1016\/j.mycmed.2022.101276_bib0004","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European conference on infections in leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.mycmed.2022.101276_bib0005","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101276_bib0006","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0007","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0008","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0009","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.14740\/jocmr2992w","article-title":"Combination antifungal therapy: a review of current data","volume":"9","author":"Campitelli","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.mycmed.2022.101276_bib0011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40588-015-0017-z","article-title":"Combination antifungal therapy: when, where, and why","volume":"2","author":"Belanger","year":"2015","journal-title":"Curr Clin Micro Rpt"},{"key":"10.1016\/j.mycmed.2022.101276_bib0012","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1111\/tid.13066","article-title":"Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders","volume":"21","author":"Qiu","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5045\/br.2017.52.3.167","article-title":"Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.mycmed.2022.101276_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.20411\/pai.v4i2.299","article-title":"Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: data from a real-life case-series","volume":"4","author":"Peri","year":"2019","journal-title":"Pathog Immun"},{"key":"10.1016\/j.mycmed.2022.101276_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.mycmed.2022.101276_bib0016","doi-asserted-by":"crossref","first-page":"myac015","DOI":"10.1093\/mmy\/myac015","article-title":"Diagnosis of mucormycosis using an intercalating dye-based quantitative PCR","volume":"60","author":"Bigot","year":"2022","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2022.101276_bib0017","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and european organization for research and treatment of cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101276_bib0018","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP n.d","year":"2021"},{"key":"10.1016\/j.mycmed.2022.101276_bib0019","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CEJ.0000000000000006","article-title":"Childhood cancer survival in France, 2000-2008","volume":"23","author":"Lacour","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.mycmed.2022.101276_bib0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/dkn027","article-title":"Risk factors for breakthrough invasive fungal infection during secondary prophylaxis","volume":"61","author":"Cornely","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101276_bib0021","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.49.3.1232-1235.2005","article-title":"Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus","volume":"49","author":"Cuenca-Estrella","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101276_bib0022","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jac\/dkg242","article-title":"Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus","volume":"51","author":"Manavathu","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101276_bib0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","article-title":"Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies","volume":"45","author":"Raad","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2022.101276_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jpids\/piu074","article-title":"A Prospective, International Cohort Study of Invasive Mold Infections in Children","volume":"4","author":"Wattier","year":"2015","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:34Z","timestamp":1761110494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1156523322000336"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101276","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal combination therapy for invasive fungal infections in a paediatric oncology and haematology department: A retrospective analysis of practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101276"}}